What are the recommended concentrations of diclofenac, baclofen, lidocaine, ketamine, and gabapentin in a compounded pain cream?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Concentrations for Compounded Pain Cream

For a compounded pain cream containing diclofenac, baclofen, lidocaine, ketamine, and gabapentin, the recommended concentrations are: diclofenac 3%, baclofen 2%, lidocaine 5%, ketamine 10%, and gabapentin 6%. 1, 2, 3, 4

Evidence-Based Concentrations for Each Component

Lidocaine

  • 5% concentration is the most commonly recommended formulation for neuropathic pain, providing local anesthesia with minimal systemic absorption 5
  • Available in both patch and cream/gel formulations, with patches being more effective than gel due to gradual delivery over hours 1
  • Should only be applied to intact skin over the area of maximal pain 5

Diclofenac

  • 3% concentration is effective for topical pain management 2
  • 1% gel is also commonly used and is often the most requested agent by patients 2
  • Should be taken with food to minimize gastrointestinal side effects when used orally 6

Ketamine

  • 10% concentration is effective for topical pain management in compounded formulations 2, 3
  • Works as an N-methyl-D-aspartate (NMDA) receptor antagonist in peripheral terminals of primary nociceptive afferents 1
  • Can be compounded with other agents to extend duration of effect to 2-3 times daily application 2

Gabapentin

  • 6% concentration is effective for topical pain management 2, 4
  • Penetration and retention in the skin is dependent on the base used, with poloxamer lecithin organogel showing the best results 4
  • Topical 5% gabapentin has shown similar reduction in nociception as systemic gabapentin in preclinical models 4

Baclofen

  • 2% concentration is typically used in compounded pain formulations 7
  • Often included in formulations for nociceptive and mixed pain 7

Application and Usage Guidelines

  • Apply to intact skin over the area of maximal pain, avoiding broken or inflamed skin 5
  • Apply 2-3 times daily for optimal pain relief 2
  • An adequate trial requires at least 3 weeks to properly assess efficacy 5
  • Most common adverse effects are mild application site reactions such as erythema or rash 5

Efficacy Considerations

  • Compounded pain creams may not show superior efficacy compared to placebo in some studies, suggesting careful consideration of cost versus benefit 7
  • The choice of vehicle/base significantly affects drug penetration and efficacy 4
  • Lipoderm or similar specialized bases may be preferred for optimal drug delivery 4
  • Pain relief typically begins within 30 minutes of application but duration varies based on formulation 2

Cautions and Monitoring

  • Monitor for local skin reactions, which are the most common adverse effects 5
  • Avoid using on broken or inflamed skin 5
  • Avoid applying external heat sources over the application area 5
  • Systemic absorption is minimal with proper application, making these formulations safer than oral alternatives 3

Special Considerations

  • For elderly patients or those with sensitive skin, consider starting with lower concentrations and titrating as needed 6
  • The efficacy of compounded formulations may depend on the specific pain condition being treated 1, 7
  • Combination therapy with these agents may provide better pain relief than monotherapy for complex pain conditions 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Analgesic effects of topical ketamine.

Minerva anestesiologica, 2015

Research

Skin permeation and antinociception of topical gabapentin formulations.

International journal of pharmaceutical compounding, 2014

Guideline

Lidocaine Ointment Dosing for Neuropathic Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pain Management with Diclofenac

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.